BioCeramic Therapeutics
Providing a quality, multidisciplinary practice for patients in need for chiropractic, physical therapy, pain management, and neurology.
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | €0.0 | round | |
$1.9m | Series B | ||
| Total Funding | 000k | ||
Related Content
BioCeramic Therapeutics Ltd. is a life sciences company that emerged as a spin-out from Imperial College London, co-founded by Dr. Molly Stevens and Professor Robert Hill. The firm is focused on the development and commercialization of bioceramic and nanostructured scaffold products. These products are engineered to address the clinical needs of patients with musculoskeletal conditions.
The company's core technology leverages bioceramics, which are specialized, biocompatible ceramic materials designed for medical use. These materials are notable for their ability to interact with biological systems without causing an adverse immune response. The product pipeline includes a range of bioceramic and nanostructured scaffolds. Scaffolds play a critical role in regenerative medicine by providing a structure that supports cell attachment, growth, and differentiation, thereby facilitating the repair and regeneration of tissues like bone and cartilage. The company's approach is designed to help heal defects by promoting the remodeling of the patient's own tissue.
Operating within the broader orthobiologics and biomaterials market, BioCeramic Therapeutics serves the medical and healthcare sectors. The primary clients for these technologies are surgeons and healthcare providers in specialties such as orthopedics. The market is driven by an aging global population, which leads to a higher incidence of age-related conditions like osteoarthritis, and a growing demand for biocompatible implant solutions. A key milestone for the company was securing its first financing round in early 2025, which provided the necessary capital to advance its product development plans. Keywords: bioceramics, nanostructured scaffolds, musculoskeletal conditions, regenerative medicine, orthobiologics, tissue engineering, biomaterials, Imperial College spin-out, bone repair, cartilage repair, medical implants, biocompatible materials, advanced ceramics, tissue regeneration, orthopedic therapies, bioactive glass, calcium phosphate, scaffold technology, medical devices, surgical implants